| Name | Title | Contact Details |
|---|
Fairfield Theatre Company is a highly acclaimed nonprofit performing arts organization located in the heart of downtown at 70 Sanford Street, Fairfield, Connecticut. FTC presents over 300 concerts and events each year featuring outstanding national talent on FTCs StageOne and The Warehouse at FTC in Fairfield. FTCs venues are widely recognized as being the best places to see live performances in the region. FTC is dedicated to providing the highest quality arts, entertainment, and educational experiences to the communities we serve. ABOUT THE WAREHOUSE AT FTC Our newest and most versatile space, The Warehouse at FTC is a 640 capacity, flexible seating theatre conveniently located in the heart of Fairfield. Designed by Michael Smith Architects in order to accommodate the widest variety of programming, The Warehouse at FTC pairs a classic industrial feel with state of the art construction and staging. Its the embodiment of the artistic vision, enterprising spirit, and community mindset that have always helped FTC grow. ABOUT STAGEONE Established in 2004, StageOne is a 225 seat venue in the heart of downtown Fairfield, Connecticut. Originally built primarily for theatre productions, StageOne is consistently voted as the best place to hear live music in the entire region because of the quality of the sound, the intimacy of the space, and the caliber of the artists. There is literally not a bad seat in the house and there are few venues in the country where the fans can be so close to the world-renowned artists who grace the stage in over 200 concerts and productions a year. The artists love to perform here and frequently cite StageOne as their absolute favorite venue. This brings out the very best in them, which is reflected in the quality of their performances and enjoyment of their fans.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Stardust Power Inc. is developing a strategically central, vertically-integrated lithium refinery capable of producing 50,000 tons per annum of battery-grade lithium. Committed to sustainability at each point in the process, the company enjoys a diversified supply of lithium from American brine sources. Stardust is comprised of leading industry, mining and finance experts, supported by a best-in-class advisory board and top technology partners. For more information, visit www.stardust-power.com.
Based in the Pacific Northwest of the United States, SSC North America is a hypercar manufacturer that specializes in limited production vehicles for elite clientele around the world. In 2007, the SSC Ultimate Aero, a high performance hypercar produced by SSC, legitimized the companys standing as a leading player in the worldwide hypercar market by officially becoming the "Worlds Fastest Production Car" as witnessed and recorded by Guinness World Records. The Ultimate Aero achieved an average two-way speed of 256.18 mph, making SSC one of only 26 manufactures in world history to hold this prestigious title. Today, SSC North America is in the late development stages of the next world record breaking hypercar, the Tuatara. With the Ultimate Aeros record setting achievements and the world renowned performance brought by the next generation Tuatara, SSC North America stands firmly as a great American hypercar company, and will continue to lead innovation in the hypercar market.